Mangoceuticals announces commercial launch of second Mango ED product

Mangoceuticals announced the official commercial launch of its second Mango ED product, which leverages the Company’s existing custom compound alongside Sildenafil, the active ingredient found in Viagra. Interested consumers can now proceed through the Company’s telemedicine platform and select either a Sildenafil-based Mango or the Company’s original Tadalafil-based Mango ED product, which leverages the active ingredient found in Cialis. Both the Sildenafil and Tadalafil-based Mango ED products are compounded with Oxytocin and L-Arginine in a tasty Mango-flavored, rapid dissolve tablet and individually packaged in a master pack of six tablets per package.